The OIC-Secretary of Health (SOH) notes the final recommendation of the HTA Council on Cerebrolysin 215.2 mg/ml, 10ml ampule for IV infusion in combination with rehabilitation or standard of care for the treatment of adults with post-ischemic stroke (date of receipt of acknowledgment: 25 April 2023). As a final recommendation, the HTA Council does not recommend the government financing of cerebrolysin in combination with rehabilitation or standard of care for the treatment of adults  with post-ischemic stroke

For further details, please refer to the documents below: